Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia

BMC Hematology

Volumn 13, Issue 1, 2013, Pages

  Ferede, Getachew ^a   Wondimeneh, Yitayih ^a  

^a UNIVERSITY OF GONDAR   (Ethiopia)

Author keywords

Anaemia; CD4 count; HAART na ve; HIV

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; DEMOGRAPHY; FEMALE; FOLLOW UP; GROUPS BY AGE; HEMOGLOBIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOCIAL STATUS; UNIVERSITY HOSPITAL;

EID: 85010298355     PISSN: None     EISSN: 20521839     Source Type: Journal    
DOI: 10.1186/2052-1839-13-8     Document Type: Article

References (23)

1. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW: Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998, 91:301–308.
2. Shah I, Murthy AK: Aplastic anemia in an HIV infected child. Indian J Pediatr 2005, 72:359–361.
3. Belperio PS, Rhew DC: Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004, 116:27–43.
4. Attili S, Singh V, Rai M, Varma D, AK G: Hematological profile of HIV patients in relation to immune status - a hospital-based cohort from Varanasi, North India. Turk J Hematol 2008, 25:13–19.
5. Savarino A, Pescarmona GP, Boelaert JR: Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences. Cell Biochem Funct 1999, 7:279–287.
6. Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, et al: Use of total lymphocyte count and hemoglobin concentration for monitoring progression of HIV infection. J Acquir Immune Defic Syndr 2005, 39:620–625.
7. Lundgren JD, Mocroft A: Anemia and survival in human immunodeficiency virus. Clin Inf Dis 2003, 37:297–303.
8. Doukas MA: Human immunodeficiency virus associated anemia. Med Clin North Am 1992, 76:699.
9. Mocroft A, Kirk O, Barton SE, Dietrich M, Proenca R, Colebunders R, Pradier C, DArminio Monforte A, Ledergerber B, Lundgren JD: Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS 1999, 13:943–950.
10. Semba RD, Martin BK, Kempen JH, Thorne JE, Wu AW: The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med 2005, 165:2229–2236.
11. Semba RD: Iron-deficiency anemia and the cycle of poverty among human immunodeficiency virus-infected women in the inner city. Clin Infect Dis 2003, 37:105–111.
12. Evans RH, Scadden DT: Haematological aspects of HIV infection. Baillieres Best Pract Res Clin Haematol 2000, 13:215–230.
13. Spivak JL: The blood in systemic disorders. Lancet 2000, 355:1707–12.
14. Kreuzer KA, Rockstroh JK, Jelkmann W, Theisen A, Spengler U, Sauerbruch T, et al: Inadequate erythropoietin response to anemia in HIV patients: relationship to serum levels of tumor necrosis factor-alpha, interleukin-6 and their soluble receptors. Br J Haematol 1997, 96:235–9.
15. Onyekachi I: Maximizing response to erythropoietin in treating HIV-associated anemia. Cleve Clin J Med 2001, 68:643–648.
16. Miller MF, Humphrey JH, Iliff PJ, Malaba LC, Mbuya NV, Stoltzfus RJ: Neonatal erythropoiesis and subsequent anemia in HIV-positive and HIV-negative Zimbabwean babies during the first year of life: a longitudinal study. BMC Infect Dis 2006, 6:1.
17. Florence M, Jean Bosco G, Joshua M, Joris D, Jan P: Anemia in Human Immunodeficiency Virus–Infected and Uninfected Women in Rwanda. Am J Trop Med Hyg 2011, 84:456–460.
18. Izaks GJ, Westendorp RGJ, Knooks DL: The definition of anaemia in older persons. JAMA 1999, 281:1714–1717.
19. Volberding P: The impact of anaemia on quality of life in human immunodeficiency virus infected patients. Clin Infect Dis 2002, 185:110–114.
20. Kreuzer KA, Rockstroh JK: Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol 1997, 75:179–87.
21. Mildvan D, Creagh T, Leitz G: Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study. Curr Med Res Opin 2007, 23:343–55.
22. Levine AM, Berhane K, Masri-Lavine L, et al: Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study. J acquir Immune defic syndr 2001, 26:28–35.
23. Semba RD, Shah N, Klein RS, et al: Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis 2002, 34:260–6.